Nitrogen-fused Heterocycles: Empowering Anticancer Drug Discovery

Jan 9, 2024Medicinal chemistry (Shariqah (United Arab Emirates))

Nitrogen-based ring structures supporting anticancer drug development

AI simplified

Abstract

Over 85% of drugs with physiological activity contain heterocyclic structures or at least one heteroatom.

  • Nitrogen-containing heterocycles are prevalent in medicinal chemistry and may play a crucial role in developing new anticancer agents.
  • These compounds exhibit significant structural variety, allowing for potential customization in creating personalized cancer treatments.
  • Computational techniques and studies on structure-activity relationships could enhance the rational design and optimization of new medications.
  • The exploration of nitrogen-containing heterocycles represents a promising area of research in addressing the challenges posed by cancer.

AI simplified

Full Text

what lands in your inbox each week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free